Fig 1: CLP induced lung injury in mice. A The animal intervention procedures of the sham and CLP groups. B H&E staining of the pathology of lung tissues. C Lung injury score. D Assessment of pulmonary edema (wet/dry ratio of lung tissue). E Assessment of pulmonary vascular permeability. F Inflammatory factors IL-1β, TNF-α, IL-6, IFN-γ, and CCL3 levels in BALF. G Inflammatory factors IL-1β, TNF-α, IL-6, IFN-γ, and CCL3 levels in lung tissue. The experiment was repeated three times (n = 5 mice/group). Student’s t-test was used for comparison between two groups. The data were presented as the mean ± SD. *P < 0.05 vs. sham
Fig 2: Neutrophil depletion alleviated the promotion of ARDS development by the FABP4 inhibitor BMS309403. A The animal intervention procedures of the CLP + BMS309403, CLP + BMS309403 + Tg, CLP + anti-Ly6G, CLP + anti-Ly6G + BMS309403, and CLP + anti-Ly6G + BMS309403 + Tg groups. B FCM analysis of neutrophil content. C FCM analysis of FABP4 expression. D H&E staining of the pathology of lung tissue and lung injury score. E Assessment of pulmonary vascular permeability. F and G IF double staining of the expression of NETs markers (Cit-H3) and neutrophil markers (MPO) to assess NETs levels in lung tissue. H Inflammatory factors IL-1β, TNF-α, IL-6, IFN-γ, and CCL3 levels. The experiment was repeated three times (n = 5 mice/group). The significance of three or more groups was compared by one-way ANOVA, followed by Tukey’s post hoc test. The data were presented as the mean ± SD. *P < 0.05 vs. sham, #P < 0.05 vs. CLP, &P < 0.05 vs. CLP + BMS309403, $P < 0.05 vs. CLP + anti-Ly6G, %P < 0.05 vs. CLP + anti-Ly6G + BMS309403
Supplier Page from CUSABIO Technology LLC for Mouse Macrophage Inflammatory Protein 1α,MIP-1α ELISA Kit